Jilin Pharmaceutical USA, Inc.
Catalog
Locations
| Location name | Address |
|---|---|
| Jilin Pharmaceutical USA, Inc. | 289 Route 33 Building A, Suite 6 Manalapan, NJ 07726 USA |
Documents
| Type | Location |
|---|---|
| Allergen Control Policy | Neimemggu Fufeng Biotechnologies Co., Ltd. |
| Allergen Control Policy | Jilin Pharmaceutical USA, Inc. |
| Allergen Control Policy | Neimenggu FuFeng |
| 3rd Party Audit Report | Neimenggu FuFeng |
| 3rd Party Audit Certificate | Neimenggu FuFeng |
| CA Transparency Act | Jilin Pharmaceutical USA, Inc. |
| Recall/Emergency/Contact List | Jilin Pharmaceutical USA, Inc. |
| Recall/Emergency/Contact List | Neimenggu FuFeng |
| Ethical Code of Conduct | Neimenggu FuFeng |
| Ethical Code of Conduct | Jilin Pharmaceutical USA, Inc. |
| FDA Registration | Neimenggu FuFeng |
| FDA Registration | Jilin Pharmaceutical USA, Inc. |
| Food Defense Plan Statement | Jilin Pharmaceutical USA, Inc. |
| Food Defense Plan Statement | Neimenggu FuFeng |
| Food Defense Plan Statement | Jilin Pharmaceutical USA, Inc - Carteret NJ |
| HARPC Food Safety Plan (Facility) | Jilin Pharmaceutical USA, Inc. |
| 3rd Party Audit Certificate | Jilin Pharmaceutical USA, Inc - Carteret NJ |
| HACCP Plan (Facility) | Jilin Pharmaceutical USA, Inc. |
| HACCP Plan (Facility) | Neimenggu FuFeng |
| Supplier Approval Program Statement | Neimenggu FuFeng |
| 3rd Party Audit Certificate | Jilin Pharmaceutical USA, Inc. |
| 3rd Party Audit Report | Jilin Pharmaceutical USA, Inc. |
| GFSI Audit Report | Jilin Pharmaceutical USA, Inc. |
| GFSI Certificate | Jilin Pharmaceutical USA, Inc. |
| GFSI Corrective Action | Jilin Pharmaceutical USA, Inc. |
| Recall Plan | Jilin Pharmaceutical USA, Inc. |
| Recall Plan | Neimenggu FuFeng |
| Bioterrorism Letter | Jilin Pharmaceutical USA, Inc. |
| Supplier Questionnaire | Neimenggu FuFeng |
| Supplier Questionnaire | Jilin Pharmaceutical USA, Inc. |
| Sustainability (Level 1) | Jilin Pharmaceutical USA, Inc. |
| Sustainability (Level 2) | Jilin Pharmaceutical USA, Inc. |
| W-9 | Jilin Pharmaceutical USA, Inc. |